SCHEMBL18979438

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL29711712	0.77	L3MBTL1 (0.40)	—
	SCHEMBL17027774	0.77	L3MBTL1 (0.40)	—
	SCHEMBL3514728	0.74	RAB9A (0.37)	POLB
	SCHEMBL3514730	0.74	RAB9A (0.37)	POLB
	SCHEMBL18979439	0.72	USP30 (0.55)	—
	SCHEMBL17027845	0.71	MAP4K4 (0.55)	TYRO3BRD4MAP4K4ABL1DYRK1A
	SCHEMBL6210544	0.70	SMN1; SMN2 (0.42)	POLB
	SCHEMBL18996615	0.67	KDM4E (0.39)	TYRO3BRD4MAP4K4F10ST14
	SCHEMBL21952101	0.66	TRPV1 (0.35)	—
	SCHEMBL20448655	0.66	RIPK1 (0.37)	KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.